Feb 27, 2025 / 10:00PM GMT
Operator
Good afternoon and welcome to Apelleus for full year 2024 business update conference call. My name is Tamia, and I will facilitate the audio portion of today's interactive broadcast. If you would like to ask a question, please press 1. Please press 0 should you need assistance during the call. At this time, I would like to turn the call over to Tren Steinmar, Abelera's chief legal and compliance officer. You may proceed.
Tryn Stimart - Abcellera Biologics Inc - Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer
Thank you. Hello everyone.
Thank you for joining us for Abelera's 2024 full year earnings call. I'm Trent Steinart, of Celera's chief legal and compliance officer. Dr. Carl Hansen, of Celera's President and CEO, and Andrew Booth.
Appelle's CFO are joining me on today's call. During this call, we anticipate making projections and forward-looking statements based on our current expectations and according to the safe harbor provisions of the Private Securities Litigation Reform Act of 1,995. Our actual
Q4 2024 Abcellera Biologics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
